145 related articles for article (PubMed ID: 35648208)
41. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
Rombouts AJM; Hugen N; Verhoeven RHA; Elferink MAG; Poortmans PMP; Nagtegaal ID; de Wilt JHW
Eur J Surg Oncol; 2018 Jul; 44(7):1018-1024. PubMed ID: 29678303
[TBL] [Abstract][Full Text] [Related]
42. [The value of MR T2WI signal intensity related parameters for predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer].
Wan LJ; Zhang CD; Zhang HM; Meng YK; Ye F; Liu Y; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):837-843. PubMed ID: 31770851
[No Abstract] [Full Text] [Related]
43. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
Lambregts DM; Vandecaveye V; Barbaro B; Bakers FC; Lambrecht M; Maas M; Haustermans K; Valentini V; Beets GL; Beets-Tan RG
Ann Surg Oncol; 2011 Aug; 18(8):2224-31. PubMed ID: 21347783
[TBL] [Abstract][Full Text] [Related]
44. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
[TBL] [Abstract][Full Text] [Related]
45. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
46. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
47. The application of the golden-angle radial sparse parallel technique in T restaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Zhou M; Huang H; Gong T; Chen M
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38822854
[TBL] [Abstract][Full Text] [Related]
48. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
[TBL] [Abstract][Full Text] [Related]
49. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
[TBL] [Abstract][Full Text] [Related]
50. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
[TBL] [Abstract][Full Text] [Related]
51. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract][Full Text] [Related]
52. Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Wang Y; Fan X; Bao H; Xia F; Wan J; Shen L; Wang Y; Zhang H; Wei Y; Wu X; Shao Y; Li X; Xu Y; Cai S; Zhang Z
Clin Chem; 2023 Jan; 69(1):88-99. PubMed ID: 36308331
[TBL] [Abstract][Full Text] [Related]
53. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
[TBL] [Abstract][Full Text] [Related]
54. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
Patel UB; Brown G; Rutten H; West N; Sebag-Montefiore D; Glynne-Jones R; Rullier E; Peeters M; Van Cutsem E; Ricci S; Van de Velde C; Kjell P; Quirke P
Ann Surg Oncol; 2012 Sep; 19(9):2842-52. PubMed ID: 22526897
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
[TBL] [Abstract][Full Text] [Related]
56. Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging.
Jang BS; Lim YJ; Song C; Jeon SH; Lee KW; Kang SB; Lee YJ; Kim JS
Radiother Oncol; 2021 Aug; 161():183-190. PubMed ID: 34139211
[TBL] [Abstract][Full Text] [Related]
57. The Diagnostic Accuracy of Magnetic Resonance Imaging in Restaging of Rectal Cancer After Preoperative Chemoradiotherapy: A Meta-Analysis and Systematic Review.
Wei MZ; Zhao ZH; Wang JY
J Comput Assist Tomogr; 2020; 44(1):102-110. PubMed ID: 31939890
[TBL] [Abstract][Full Text] [Related]
58. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
59. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
60. Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer.
van Griethuysen JJM; Lambregts DMJ; Trebeschi S; Lahaye MJ; Bakers FCH; Vliegen RFA; Beets GL; Aerts HJWL; Beets-Tan RGH
Abdom Radiol (NY); 2020 Mar; 45(3):632-643. PubMed ID: 31734709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
